Oral: Drug Resistance in Infection Modelling

Home / Oral: Drug Resistance in Infection Modelling

Oral: Drug Resistance in Infection Modelling

Towards Model-Based Drug Development of New Therapeutics for Hepatitis C Virus

Thursday 16 October, 2025

Objectives: The FDA “critical path” document characterizes model-based drug development (MBDD) as the development and application of pharmaco-statistical models of…

Read more

A Pharmacokinetic-Pharmacodynamic (PKPD) Model Characterizing Resistance for Predictions of Bacterial Kill in vivo

Thursday 16 October, 2025

Objectives: Within the infectious disease area, the pharmacokinetic (PK) -pharmacodynamic (PD) characterization is generally limited to the establishment of the so…

Read more

Treating Resistant Gram-Negatives: Bedside to Bench and Back

Thursday 16 October, 2025

Objective: London is a culturally diverse city, and this extends to diversity in bacterial pathogens. Multi-drug resistant (MDR) Gram-negatives are…

Read more